A Study of JNJ-64140284 Solid Dose Formulations in Healthy Male Participants
Status:
Terminated
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetic profile of a single dose of two
solid dosage formulations relative to a reference formulation (solution in polyethylene
glycol-400 [PEG-400]) of JNJ-64140284 in healthy male participants under fasting condition
and to assess the effect of food on the bioavailability of two solid dosage formulations of
JNJ-64140284.